ABOUT US
We strive for better healthcare outcomes.
We are a purpose-driven division.
MicroMed Solutions, a division of LasX Industries, is a full-service CDMO—deploying microfluidic technology and thin-film laser converting to bring point-of-care devices to the marketplace. We care deeply about partnering with our clients every step-of-the-way from product development to high volume commercial production to advance medical care and improve health outcomes. And yes, we are ISO 13485 certified.
ISO-13485 Certification
Thin-Film Laser Converting
Microfluidic Technology
Get to know our value system and the way we see our role in medical innovation.
-
We deliver products which expand access and improve therapeutic outcomes.
-
We develop people to achieve their fullest potential to deliver best-in-class products.
-
We channel a track record of success in applying technologies and processes which serve customer objectives.
-
We deploy novel process technologies to ensure state-of-the-art product performance and manufacturing excellence.
-
We leverage extensive supply chain relationships to deliver mission critical results.
-
We provide best practice, life cycle concurrent process development to rapidly demonstrate product feasibility.
We ensure quality is designed within the manufacturing process to achieve regulatory compliance.
Vision
We improve the health of humans, animals, and the environment through expanding access to advanced diagnostics.
Mission
We collaborate with biotech innovators to design and manufacture cost-effective microfluidic cartridges & chips.
Our partnership network
The medical device development process is complex. We are proud to cultivate relationships with a number of companies who specialize in instrumentation, chemistry, material science, and more.
Our History
-
2002
Launched first device converting program.
-
2011
Received patent for precision lamination.
-
2012
Achieved ISO 13485 certification.
-
2014
Installed first automated workcell for E. coli testing.
-
2015
Launched first fertility diagnostics program into production.
-
2018
Supported over 30 medical device programs.
-
2020
Supported multiple COVID-19 device programs.
-
2022
Began development services for microfluidic chips & cartridges.
